$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Dietary Isoliquiritigenin at a Low Dose Ameliorates Insulin Resistance and NAFLD in Diet-Induced Obesity in C57BL/6J Mice 원문보기

International journal of molecular sciences, v.19 no.10, 2018년, pp.3281 -   

Lee, Youngmi (Department of Food Science and Nutrition, Kyungpook National University, 1370 San-Kyuk Dong Puk-Ku, Daegu 41566, Korea) ,  Kwon, Eun-Young (6k5rsg@hanmail.net (Y.L.)) ,  Choi, Myung-Sook (savage20@naver.com (E.-Y.K.))

Abstract AI-Helper 아이콘AI-Helper

Isoliquiritigenin (ILG) is a flavonoid constituent of Glycyrrhizae plants. The current study investigated the effects of ILG on diet-induced obesity and metabolic diseases. C57BL/6J mice were fed a normal diet (AIN-76 purified diet), high-fat diet (40 kcal% fat), and high-fat diet +0.02% (w/w) ILG f...

주제어

참고문헌 (57)

  1. 1. Drewnowski A. Specter S.E. Poverty and Obesity: The Role of Energy Density and Energy Costs Am. J. Clin. Nutr. 2004 79 6 16 10.1093/ajcn/79.1.6 14684391 

  2. 2. Prentice A.M. Jebb S.A. Fast Foods, Energy Density and Obesity: A Possible Mechanistic Link Obes. Rev. 2003 4 187 194 10.1046/j.1467-789X.2003.00117.x 14649369 

  3. 3. Jung U.J. Choi M. Obesity and its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease Int. J. Mol. Sci. 2014 15 6184 6223 10.3390/ijms15046184 24733068 

  4. 4. Spiegelman B.M. Flier J.S. Obesity and the Regulation of Energy Balance Cell 2001 104 531 543 10.1016/S0092-8674(01)00240-9 11239410 

  5. 5. Masoodi M. Kuda O. Rossmeisl M. Flachs P. Kopecky J. Lipid Signaling in Adipose Tissue: Connecting Inflammation & Metabolism Biochim. Biophys. Acta 2015 1851 503 518 25311170 

  6. 6. Guilherme A. Virbasius J.V. Puri V. Czech M.P. Adipocyte Dysfunctions Linking Obesity to Insulin Resistance and Type 2 Diabetes Nat. Rev. Mol. Cell Boil. 2008 9 367 377 10.1038/nrm2391 18401346 

  7. 7. Bjorndal B. Burri L. Staalesen V. Skorve J. Berge R.K. Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents J. Obes. 2011 2011 490650 10.1155/2011/490650 21403826 

  8. 8. Choi S.H. Ginsberg H.N. Increased very Low Density Lipoprotein (VLDL) Secretion, Hepatic Steatosis, and Insulin Resistance Trends Endocrinol. Metab. 2011 22 353 363 10.1016/j.tem.2011.04.007 21616678 

  9. 9. Shibata S. A Drug over the Millennia: Pharmacognosy, Chemistry, and Pharmacology of Licorice Yakugaku Zasshi 2000 120 849 862 10.1248/yakushi1947.120.10_849 11082698 

  10. 10. Watanabe Y. Nagai Y. Honda H. Okamoto N. Yamamoto S. Hamashima T. Ishii Y. Tanaka M. Suganami T. Sasahara M. Isoliquiritigenin Attenuates Adipose Tissue Inflammation in vitro and Adipose Tissue Fibrosis through Inhibition of Innate Immune Responses in Mice Sci. Rep. 2016 6 23097 10.1038/srep23097 26975571 

  11. 11. Honda H. Nagai Y. Matsunaga T. Okamoto N. Watanabe Y. Tsuneyama K. Hayashi H. Fujii I. Ikutani M. Hirai Y. Isoliquiritigenin is a Potent Inhibitor of NLRP3 Inflammasome Activation and Diet-induced Adipose Tissue Inflammation J. Leukoc. Biol. 2014 96 1087 1100 10.1189/jlb.3A0114-005RR 25210146 

  12. 12. Kim Y.M. Kim T.H. Kim Y.W. Yang Y.M. Hwang S.J. Lee J.R. Kim S.C. Kim S.G. Inhibition of Liver X Receptor-Α-Dependent Hepatic Steatosis by Isoliquiritigenin, a Licorice Antioxidant Flavonoid, as Mediated by JNK1 Inhibition Free Radic. Biol. Med. 2010 49 1722 1734 10.1016/j.freeradbiomed.2010.09.001 20840863 

  13. 13. Park S. Choe Y. Kim J. Chang K. Lee H. Lee D. Isoliquiritigenin Impairs Insulin Signaling and Adipocyte Differentiation through the Inhibition of Protein-Tyrosine Phosphatase 1B Oxidation in 3T3-L1 Preadipocytes Food Chem. Toxicol. 2016 93 5 12 10.1016/j.fct.2016.04.017 27117918 

  14. 14. Du F. Gesang Q. Cao J. Qian M. Ma L. Wu D. Yu H. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice Int. J. Mol. Sci. 2016 17 1932 10.3390/ijms17111932 27869741 

  15. 15. Liu X. Zhu Q. Zhang M. Yin T. Xu R. Xiao W. Wu J. Deng B. Gao X. Gong W. Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice Via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway Oxid. Med. Cell. Longev. 2018 2018 7161592 10.1155/2018/7161592 29854090 

  16. 16. Strycharz J. Rygielska Z. Swiderska E. Drzewoski J. Szemraj J. Szmigiero L. Sliwinska A. SIRT1 as a Therapeutic Target in Diabetic Complications Curr. Med. Chem. 2018 25 1002 1035 10.2174/0929867324666171107103114 29110598 

  17. 17. Gooda Sahib N. Saari N. Ismail A. Khatib A. Mahomoodally F. Abdul Hamid A. Plants’ Metabolites as Potential Antiobesity Agents Sci. World J. 2012 2012 436039 10.1100/2012/436039 22666121 

  18. 18. Loftus T.M. Jaworsky D.E. Frehywot G.L. Townsend C.A. Ronnett G.V. Lane M.D. Kuhajda F.P. Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors Science 2000 288 2379 2381 10.1126/science.288.5475.2379 10875926 

  19. 19. Nguyen P. Leray V. Diez M. Serisier S. Bloc’h J.L. Siliart B. Dumon H. Liver Lipid Metabolism J. Anim. Physiol. Anim. Nutr. 2008 92 272 283 10.1111/j.1439-0396.2007.00752.x 18477307 

  20. 20. Musso G. Gambino R. Cassader M. Recent Insights into Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) Prog. Lipid Res. 2009 48 1 26 10.1016/j.plipres.2008.08.001 18824034 

  21. 21. Fraulob J.C. Ogg-Diamantino R. Fernandes-Santos C. Aguila M.B. Mandarim-de-Lacerda C.A. A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet J. Clin. Biochem. Nutr. 2010 46 212 223 10.3164/jcbn.09-83 20490316 

  22. 22. Van der Heijden R.A. Sheedfar F. Morrison M.C. Hommelberg P.P. Kor D. Kloosterhuis N.J. Gruben N. Youssef S.A. De Bruin A. Hofker M.H. High-Fat Diet Induced Obesity Primes Inflammation in Adipose Tissue Prior to Liver in C57BL/6j Mice Aging 2015 7 256 268 10.18632/aging.100738 25979814 

  23. 23. Roat R. Rao V. Doliba N.M. Matschinsky F.M. Tobias J.W. Garcia E. Ahima R.S. Imai Y. Alterations of Pancreatic Islet Structure, Metabolism and Gene Expression in Diet-Induced Obese C57BL/6J Mice PLoS ONE 2014 9 e86815 10.1371/journal.pone.0086815 24505268 

  24. 24. Barthel A. Schmoll D. Novel Concepts in Insulin Regulation of Hepatic Gluconeogenesis Am. J. Physiol. Endocrinol. Metab. 2003 285 E685 E692 10.1152/ajpendo.00253.2003 12959935 

  25. 25. Kubota T. Kubota N. Kumagai H. Yamaguchi S. Kozono H. Takahashi T. Inoue M. Itoh S. Takamoto I. Sasako T. Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle Cell Metab. 2011 13 294 307 10.1016/j.cmet.2011.01.018 21356519 

  26. 26. Cho H. Mu J. Kim J.K. Thorvaldsen J.L. Chu Q. Crenshaw E.B. 3rd Kaestner K.H. Bartolomei M.S. Shulman G.I. Birnbaum M.J. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKB Beta) Science 2001 292 1728 1731 10.1126/science.292.5522.1728 11387480 

  27. 27. Kido Y. Burks D.J. Withers D. Bruning J.C. Kahn C.R. White M.F. Accili D. Tissue-Specific Insulin Resistance in Mice with Mutations in the Insulin Receptor, IRS-1, and IRS-2 J. Clin. Investig. 2000 105 199 205 10.1172/JCI7917 10642598 

  28. 28. Boss O. Samec S. Paoloni-Giacobino A. Rossier C. Dulloo A. Seydoux J. Muzzin P. Giacobino J. Uncoupling Protein-3: A New Member of the Mitochondrial Carrier Family with Tissue-specific Expression FEBS Lett. 1997 408 39 42 10.1016/S0014-5793(97)00384-0 9180264 

  29. 29. Choi C.S. Fillmore J.J. Kim J.K. Liu Z.X. Kim S. Collier E.F. Kulkarni A. Distefano A. Hwang Y.J. Kahn M. Overexpression of Uncoupling Protein 3 in Skeletal Muscle Protects Against Fat-Induced Insulin Resistance J. Clin. Investig. 2007 117 1995 2003 10.1172/JCI13579 17571165 

  30. 30. Boudina S. Sena S. Sloan C. Tebbi A. Han Y.H. O’neill B.T. Cooksey R.C. Jones D. Holland W.L. McClain D.A. Early Mitochondrial Adaptations in Skeletal Muscle to Diet-Induced Obesity are Strain Dependent and Determine Oxidative Stress and Energy Expenditure but Not Insulin Sensitivity Endocrinology 2012 153 2677 2688 10.1210/en.2011-2147 22510273 

  31. 31. Sharma B.K. Patil M. Satyanarayana A. Negative Regulators of Brown Adipose Tissue (BAT)-mediated Thermogenesis J. Cell. Physiol. 2014 229 1901 1907 10.1002/jcp.24664 24809334 

  32. 32. Seale P. Bjork B. Yang W. Kajimura S. Chin S. Kuang S. Scime A. Devarakonda S. Conroe H.M. Erdjument-Bromage H. PRDM16 Controls a Brown Fat/Skeletal Muscle Switch Nature 2008 454 961 967 10.1038/nature07182 18719582 

  33. 33. Seale P. Kajimura S. Yang W. Chin S. Rohas L.M. Uldry M. Tavernier G. Langin D. Spiegelman B.M. Transcriptional Control of Brown Fat Determination by PRDM16 Cell Metab. 2007 6 38 54 10.1016/j.cmet.2007.06.001 17618855 

  34. 34. Schug T.T. Li X. Sirtuin 1 in Lipid Metabolism and Obesity Ann. Med. 2011 43 198 211 10.3109/07853890.2010.547211 21345154 

  35. 35. Baur J.A. Ungvari Z. Minor R.K. Le Couteur D.G. De Cabo R. Are Sirtuins Viable Targets for Improving Healthspan and Lifespan? Nat. Rev. Drug Discov. 2012 11 443 461 10.1038/nrd3738 22653216 

  36. 36. Alcaín F.J. Villalba J.M. Sirtuin Activators Expert Opin. Ther. Pat. 2009 19 403 414 10.1517/13543770902762893 19441923 

  37. 37. Boutant M. Joffraud M. Kulkarni S.S. García-Casarrubios E. García-Roves P.M. Ratajczak J. Fernández-Marcos P.J. Valverde A.M. Serrano M. Cantó C. SIRT1 Enhances Glucose Tolerance by Potentiating Brown Adipose Tissue Function Mol. Metab. 2015 4 118 131 10.1016/j.molmet.2014.12.008 25685699 

  38. 38. Poher A. Altirriba J. Veyrat-Durebex C. Rohner-Jeanrenaud F. Brown Adipose Tissue Activity as a Target for the Treatment of Obesity/Insulin Resistance Front. Physiol. 2015 6 4 10.3389/fphys.2015.00004 25688211 

  39. 39. López-Jaramillo P. Gómez-Arbeláez D. López-López J. López-López C. Martínez-Ortega J. Gómez-Rodríguez A. Triana-Cubillos S. The Role of Leptin/Adiponectin Ratio in Metabolic Syndrome and Diabetes Horm. Mol. Biol. Clin. Investig. 2014 18 37 45 10.1515/hmbci-2013-0053 25389999 

  40. 40. Dandona P. Aljada A. Bandyopadhyay A. Inflammation: The Link between Insulin Resistance, Obesity and Diabetes Trends Immunol. 2004 25 4 7 10.1016/j.it.2003.10.013 14698276 

  41. 41. Rosen E.D. Spiegelman B.M. Adipocytes as Regulators of Energy Balance and Glucose Homeostasis Nature 2006 444 847 853 10.1038/nature05483 17167472 

  42. 42. Kim A.Y. Park Y.J. Pan X. Shin K.C. Kwak S. Bassas A.F. Sallam R.M. Park K.S. Alfadda A.A. Xu A. Obesity-Induced DNA Hypermethylation of the Adiponectin Gene Mediates Insulin Resistance Nat. Commun. 2015 6 7585 10.1038/ncomms8585 26139044 

  43. 43. Yamauchi T. Kamon J. Minokoshi Y.A. Ito Y. Waki H. Uchida S. Yamashita S. Noda M. Kita S. Ueki K. Adiponectin Stimulates Glucose Utilization and Fatty-Acid Oxidation by Activating AMP-Activated Protein Kinase Nat. Med. 2002 8 1288 1295 10.1038/nm788 12368907 

  44. 44. Finucane F. Luan J. Wareham N. Sharp S. O’Rahilly S. Balkau B. Flyvbjerg A. Walker M. Højlund K. Nolan J. Correlation of the Leptin: Adiponectin Ratio with Measures of Insulin Resistance in Non-Diabetic Individuals Diabetologia 2009 52 2345 2349 10.1007/s00125-009-1508-3 19756488 

  45. 45. Bing C. Is Interleukin-1β a Culprit in Macrophage-Adipocyte Crosstalk in Obesity? Adipocyte 2015 4 149 152 10.4161/21623945.2014.979661 26167419 

  46. 46. Gao D. Madi M. Ding C. Fok M. Steele T. Ford C. Hunter L. Bing C. Interleukin-1β Mediates Macrophage-Induced Impairment of Insulin Signaling in Human Primary Adipocytes Am. J. Physiol. Endocrinol. Metab. 2014 307 E289 E304 10.1152/ajpendo.00430.2013 24918199 

  47. 47. Sell H. Dietze-Schroeder D. Kaiser U. Eckel J. Monocyte Chemotactic Protein-1 is a Potential Player in the Negative Cross-Talk between Adipose Tissue and Skeletal Muscle Endocrinology 2006 147 2458 2467 10.1210/en.2005-0969 16439461 

  48. 48. Chang T. Chen J. Emerging Role of Chemokine CC Motif Ligand 4 Related Mechanisms in Diabetes Mellitus and Cardiovascular Disease: Friends Or Foes? Cardiovasc. Diabetol. 2016 15 117 10.1186/s12933-016-0439-9 27553774 

  49. 49. Folch J. Lees M. Sloane Stanley G.H. A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues J. Biol. Chem. 1957 226 497 509 13428781 

  50. 50. Hulcher F.H. Oleson W.H. Simplified Spectrophotometric Assay for Microsomal 3-Hydroxy-3-Methylglutaryl CoA Reductase by Measurement of Coenzyme A J. Lipid Res. 1973 14 625 631 4147523 

  51. 51. Bradford M.M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding Anal. Biochem. 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051 

  52. 52. Lazarow P.B. [19] Assay of peroxisomal β-oxidation of fatty acids Methods Enzymol. 1981 72 315 319 10.1016/S0076-6879(81)72021-4 7031421 

  53. 53. Davidson A.L. Arion W.J. Factors Underlying Significant Underestimations of Glucokinase Activity in Crude Liver Extracts: Physiological Implications of Higher Cellular Activity Arch. Biochem. Biophys. 1987 253 156 167 10.1016/0003-9861(87)90648-5 3813560 

  54. 54. Alegre M. Fillat C. Guinovart J.J. Determination of Glucose-6-Phosphatase Activity using the Glucose Dehydrogenase-Coupled Reaction Anal. Biochem. 1988 173 185 189 10.1016/0003-2697(88)90176-5 2847588 

  55. 55. Bentle L.A. Lardy H.A. Interaction of Anions and Divalent Metal Ions with Phosphoenolpyruvate Carboxykinase J. Biol. Chem. 1976 251 2916 2921 1270433 

  56. 56. Shapiro D.J. Nordstrom J.L. Mitschelen J.J. Rodwell V.W. Schimke R.T. Micro Assay for 3-Hdyroxy-3-Methylglutaryl-CoA Reductase in Rat Liver and in L-Cell Fibroblasts Biochim. Biophys. Acta 1974 370 369 377 10.1016/0005-2744(74)90098-9 4441486 

  57. 57. Gillies P.J. Rathgeb K.A. Perri M.A. Robinson C.S. Regulation of Acyl-CoA: Cholesterol Acyltransferase Activity in Normal and Atherosclerotic Rabbit Aortas: Role of a Cholesterol Substrate Pool Exp. Mol. Pathol. 1986 44 329 339 10.1016/0014-4800(86)90046-8 3720921 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로